Publications by authors named "Beata Mehes"

Claim this Profile
F
First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitor.
Ewa Gatlik, Beata Mehes, Emilie Voltz, Ulrike Sommer, Elaine Tritto

Clin Transl Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function.
Ildiko Madurka, Alexander Vishnevsky, Joan B Soriano, Stephanus J Gans, Danilo Joel Salazar Ore, Beata Mehes

Infection· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis